RenovoRx (RNXT) Other Non-Current Assets (2020 - 2026)

RenovoRx's (RNXT) quarterly Other Non-Current Assets came in at $200000.0 in Q2 2026, up 56.25% quarter-over-quarter from $128000.0 in Q1 2024.

Analysis

RenovoRx (RNXT) Other Non-Current Assets (2020 - 2026) Analysis & Trends

RenovoRx has disclosed Other Non-Current Assets across 5 years of filings, most recently posting $200000.0 for Q2 2026.

In Q2 2026, Other Non-Current Assets changed N/A year-over-year to $200000.0; the TTM figure through Jun 2026 stood at $200000.0 (changed N/A YoY), while the FY2023 annual figure was $101000.0, changed N/A from the prior year.
Other Non-Current Assets came in at $200000.0 for Q2 2026 at RenovoRx, up from $128000.0 in the prior quarter.
In the past five years, Other Non-Current Assets ranged from a high of $246000.0 in Q1 2023 to a low of $36000.0 in Q2 2023.
Average Other Non-Current Assets over 3 years is $125333.3, with a median of $114500.0 recorded in 2023.
The largest YoY upside for Other Non-Current Assets was 47.97% in 2024 against a maximum downside of 47.97% in 2024.
Over 3 years, Other Non-Current Assets stood at $101000.0 in 2023, then gained by 26.73% to $128000.0 in 2024, then surged by 56.25% to $200000.0 in 2026.
Per Business Quant data, the three most recent Other Non-Current Assets figures were $200000.0 in Q2 2026, $128000.0 in Q1 2024, and $101000.0 in Q4 2023.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Abbott Laboratories	179.84 Bn	174.23 Bn	7.27 Bn	-
2	Intuitive Surgical	128.02 Bn	122.81 Bn	1.96 Bn	-
3	Medtronic	117.28 Bn	108.46 Bn	6.34 Bn	4.32 Bn
4	Stryker	103.92 Bn	100.44 Bn	4.50 Bn	3.23 Bn
5	Boston Scientific	63.51 Bn	62.97 Bn	3.85 Bn	45.22 Bn
6	Edwards Lifesciences	49.96 Bn	45.70 Bn	1.35 Bn	616.40 Mn
7	Alcon	32.86 Bn	31.40 Bn	1.68 Bn	434.00 Mn
8	Dexcom	32.25 Bn	30.30 Bn	830.00 Mn	273.70 Mn
9	Steris	20.74 Bn	20.26 Bn	684.20 Mn	215.10 Mn
10	RenovoRx	82.06 Mn	82.06 Mn	766,000.00	200,000.00

Historic Data

Download Data